Drug Costs
As Seen In: BenefitsPRO
The future of pharmacy benefits isn’t transparency. It’s access.
For years, pharmacy benefit reform has centered on transparency. Employers have pushed for greater visibility into drug pricing,…
As Seen In: Drug Topics
Understanding the restructure of US pharmacy benefits
For years, much of the conversation about pharmacy benefits has focused on reform: greater transparency, clearer economics and…
As Seen In: Pharmaceutical Commerce
Why pharma needs a new path to market
New Pharmaceutical Commerce OpEd explores how direct access is reshaping the future of pharmaceutical market access.
3 ways the modern prescription experience is starting to look more like modern commerce
New direct-to-patient prescription models are emerging as consumers demand the same convenience, transparency, and digital control they experience…
Prescryptive Helps Power LillyDirect®, Supporting Direct-to-Patient Access
Redmond, WA – May 6, 2026 – Prescryptive Health today announced it serves as a technology platform helping to…
More direct ways of selling and buying prescription drugs was the talk at Asembia
At this year’s Asembia Specialty Pharmacy Summit, one theme stood out: the growing momentum behind more direct ways…
NCPDP webinar: How real-time Rx workflow integration puts patients first, saves time & money, and improves outcomes
There’s a shift happening in healthcare – from something done to patients to something managed by consumers. What…
As Seen In: SHRM
GLP-1 pills are here: What does it mean for employers?
Will GLP-1 pills change how employers approach coverage? It’s an important question, but the answer isn't so straightforward.
As Seen In: EBN
As Ozempic costs fall, demand for weight-loss drugs is set to surge
On the surface, lower GLP-1 prices should make these therapies easier to manage. But as Rae McMahan, SVP…
Direct access isn’t a program – it’s market design
Welcome to a direct access marketplace, where incentives are aligned by design so access becomes the default outcome.
As Seen In: Reuters
Data shows US advertising spend increasing for pharma manufacturers
Even with increased availability, access to GLP-1 therapies can be challenging for employers and healthcare consumers due to…
Redefining drug access: How the Direct Marketplace helps transform sustainable drug pricing, patient affordability, and innovation
For decades, the U.S. drug distribution model has depended on a complex web of intermediaries — pharmacy benefit…